Full Press Release Details
HOLLISTON, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will participate in The Benchmark Company, LLC One-on-One Conference at The Pfister Hotel in Milwaukee, Wisconsin on Thursday, June 2, 2016.
Jeffrey A. Duchemin, Chief Executive Officer and President; Robert E. Gagnon, Chief Financial Officer; and Corey Manchester, Director, Finance and Investor Relations will attend the conference and will be available for one-on-one meetings with investors between 8:00 AM to 3:15 PM CST.
Investors interested in arranging a meeting with Harvard Bioscience at the conference should contact Kathy Ureda, Conference Administrator, at kureda@benchmarkcompany.com or 414-203-5560.
About Harvard Bioscience
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, GE Healthcare, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China. For more information, please visit our website at www.harvardbioscience.com.
Contact Data
Director, Finance and Investor Relations
Susan Forman or Laura Radocaj